Action Seniors! Exercise to Prevent Falls

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT01029171
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
344
1
2
104
3.3

Study Details

Study Description

Brief Summary

This study will be a randomized controlled trial to determine the efficacy of the Otago Exercise Program (OEP) on falls among seniors with a history of falls.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Home-based balance and strength retraining exercise program.
  • Behavioral: control; usual care
N/A

Detailed Description

A total of 344 community-dwelling adults aged 70 years and older who are referred to a falls clinic secondary to seeking medical attention due to a fall will be randomized to either the 12-month OEP group or usual care. There will be three measurement sessions: baseline, 6 months, and 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
344 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
"Action Seniors!: A 12 Month Randomized Controlled Trial of a Home Based Strength and Balance Retraining Program in Reducing Falls.
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Jul 1, 2018
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

OEP (Otago Exercise Program; home-based balance and strength retraining program)

Behavioral: Home-based balance and strength retraining exercise program.
A 12-month home-based balance and strength restraining program delivered by a physical therapist

Active Comparator: 2

CON (control; usual care)

Behavioral: control; usual care
Usual care as prescribed by geriatrician.

Outcome Measures

Primary Outcome Measures

  1. Falls over a 12 month period. [12 months]

Secondary Outcome Measures

  1. Secondary outcomes of interest include: 1) physiological falls risk; 2) mobility; 3) cognitive function; and 4) economic evaluation. [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
70 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Adults older than or 70 years attending a Falls Prevention Clinic Service;

  2. Understands, speaks, and reads English proficiently;

  3. MMSE 8 score > 24/30;

  4. Had one documented non-syncopal fall in the last 12 months and one of the following:

  1. A Physiological Profile Assessment (PPA) score of at least 1 SD above normal; OR 2) Timed Up and Go Test (TUG) performance of greater than 15 seconds; OR 3) One additional documented non-syncopal fall in the previous 12 months;
  1. Expected to live greater than 12 months;

  2. Community-dwelling (i.e., not residing in a nursing home, extended care unit, or assisted-care facility);

  3. Able to walk 3 meters with or without an assistive device; and

  4. Able to provide written informed consent.

Exclusion Criteria:
  1. Diagnosed with a neurodegenerative disease (e.g., Parkinson's disease);

  2. Diagnosed with dementia (of any type);

  3. Had a stroke;

  4. Have clinically significant peripheral neuropathy or severe musculoskeletal or joint disease; or

  5. Have a history indicative of carotid sinus sensitivity (i.e., syncopal falls).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aging, Mobility, and Cognitive Neuroscience Laboratory, Vancouver Falls Prevention Clinic, University of British Columbia Vancouver British Columbia Canada

Sponsors and Collaborators

  • University of British Columbia
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: Teresa Liu-Ambrose, University of British Columbia
  • Study Director: Karim Khan, Ph.D, University of British Columbia
  • Study Director: Larry Dian, MD, University of British Columbia
  • Study Director: Wendy Cook, MD, University of British Columbia
  • Study Director: Penny Brasher, Ph.D, University of British Columbia
  • Study Director: Carlo Marra, Ph.D, University of British Columbia
  • Study Director: Jennifer Davis, Ph.D, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Teresa Liu-Ambrose, Principal Investigator, University of British Columbia
ClinicalTrials.gov Identifier:
NCT01029171
Other Study ID Numbers:
  • H04-70171
First Posted:
Dec 9, 2009
Last Update Posted:
Oct 10, 2018
Last Verified:
Oct 1, 2018
Keywords provided by Teresa Liu-Ambrose, Principal Investigator, University of British Columbia

Study Results

No Results Posted as of Oct 10, 2018